Friday, 20 May 2016

Clinical Mass Spectrometry Facing Uncertain Path to Broad Adoption - GenomeWeb


Clinical Mass Spectrometry Facing Uncertain Path to Broad Adoption
GenomeWeb
... of the enormous improvement in patient convenience and the really profound cost improvement compared to people having to go to a clinic or a doctor's office and get blood drawn by a phlebotomist and then ship those samples cold by FedEx," he added.



from phlebotomist - Google News http://bit.ly/2400Mvc

No comments:

Post a Comment